How to Successfully Complete a Narcotic Tapering with Functional Restoration

Size: px
Start display at page:

Download "How to Successfully Complete a Narcotic Tapering with Functional Restoration"

Transcription

1 How to Successfully Complete a Narcotic Tapering with Functional Restoration Fernando Branco M.D. F.A.A.P.M.R. Medical Director Rosomoff Comprehensive Rehabilitation Center and Brucker Biofeedback Center Miami Jewish Health Systems Disclaimer: I have no financial relationship in regard to the content of this presentation

2 Disclaimer I am the Medical Director of the Rosomoff Comprehensive Rehabilitation Center at MJHS This Presentations does not contain off-label and/or investigational use of drugs or products

3 Conundrums of Chronic Pain Care: Avoid Overuse of Narcotics Functional Restoration Return to Work Treat Psychological and Physical Problems Avoid Overuse of Interventional Treatments More Deaths from prescription drugs than illicit drugs, Fort Lauderdale had more Pain Clinics than McDonald s

4 P A I N Can t see it Can t measure it Can t diagnose it on x-ray or MRI 75% of general population will have abnormal MRIs bulging or herniated discs or narrowing..and NO PAIN.

5 Pain Cycles

6 Drug Addict? Drug Abuse? Excessive use of a drug for purposes for which it is not medically intended.

7 The Risk of Addiction Published rates of abuse and/or addiction in chronic pain populations are 3-19% Known risk factors for addiction to any substance are good predictors for opioid abuse 1. Past cocaine use, h/o of alcohol or cannabis use 2. Lifetime history of substance use disorder 3. Family history of substance abuse, history of legal problems and drug and alcohol abuse 4. Tobacco dependence 5. History of severe depression and anxiety Ives et al 2006 Reid et al 2002 Michna et al 2004 Akbik et al 2006

8 Addiction is A primary, chronic, neurobiological disease with genetic, psychosocial and environmental factors influencing its development and manifestations A clinical syndrome: Loss of control Compulsive use Continued use despite harm Craving Savage SR et al JPain Symptom Manage 2003

9 Pseudoaddiction Opiophobia Overestimate potency and duration of action Fear of being scammed Fear of addiction potential Morgan J 1985 Smith 1989

10 Yellow Flags Complaints of more medications needed Drug hoarding Requesting specific pain medications Openly acquiring similar medications from other providers Occasional unsanctioned dose escalation Nonadherence to other recommendations for pain therapy Passik SD Mayo Clinic Proc 2009

11 Red Flags Deterioration in functioning at work and socially Illegal activities selling, forging, buying from nonmedical sources Injecting and snorting medication Multiple episodes of lost or stolen scripts Resistance to change therapy despite adverse effects Refusal to comply with random drug screens Concurrent abuse of alcohol or illicit drugs Use of multiple physicians and pharmacies Passik SD Mayo Clinic Proc 2009

12 Narcotic Cycle Patients need higher doses to achieve results = TOLERANCE Eventually lack of pain relief may lead to steady increases in amount and types of pain medication Long term use of narcotics leads to OPIOD INDUCED ABNORMAL PAIN SENSITIVITY

13 Narcotics Eliminate production of your own body s ENDORPHINS Shut the endorphin system down Lead to HYPERalgesia and HYPERsensitivity to pain

14 Journal of Opioid Management Significant pain reduction in chronic pain patients after detoxification from high-dose opioids Sept/Oct of the 23 patients showed marked decrease in pain following tapering from narcotics!!

15 Publications Opioid-induced hyperalgesia: pathophysiology & clinical implications: Journal of Opioid Management 2008 Opioid induced abnormal pain sensitivity Current Pain Headache Report 2006 Adverse effects of chronic opioid therapy for chronic musculoskeletal pain National Rev of Rheumatology 2010 Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients Journal of Pain 2009

16 SERIOUS SIDE EFFECTS Narcotics slow down the action of the bowel / intestines resulting in severe constipation almost always requiring another medication to help relieve this symptom Urinary retention inability to empty bladder most often in males Hypogonadism decreased sex drive, erectile dysfunction often requires need for additional meds Testosterone therapy

17 What is the Solution?

18 MYOFASCIAL SYNDROME Sciatica Neuropathy Sinus problems / dental pain Carpal Tunnel Migraine Leads to misdiagnosis & incorrect tx J. Travell, 1976

19

20

21 Goals of Treatment Improve quality of life Restore optimum levels of function Reduce or eliminate pain Reduce or eliminate addictive pain medications Enable become independent of the healthcare system (related to pain)

22 EFFECTIVE TREATMENT Return to the basics: Physical and Psychological Rehabilitation Physical Medicine True Multidisciplinary Approach What is the definition of insanity? "The definition of insanity is doing the same thing over and over and expecting a different result. Benjamin Franklin, Albert Einstein, Chinese Anonymous

23 Outpatient Weaning Setting s Office Outpatient drug detox program Outpatient Comprehensive Pain Management Program (community weaning) Patient Characteristics On lower opioid dose, simpler medication plan (1-2 meds), more gradual wean Motivated Low to medium psychosocial issues Community social support for plan Weaning Process Speed of weaning: dose decrease by 20-25% every days Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status Support: Meds for withdrawal (temporary), physical rehabilitation (functional approach), follow-up every 1-2 weeks, but available by phone daily, proactive check-in; cognitive behavioral approach Case Management Red flags: Increased pain complaints: Can t bear it, Carrier did not approve X, Equipment did not arrive, pharmacy issues, worrisome symptoms. Actions: contact injured worker in person if possible, review treatment recommendations and symptoms management, contact treating team, return to provider if not able to assure compliance, do not approve increase in meds or new diagnostic evaluations or treatment changes unless recommended by current treatment team; disallow return to prior prescribers.

24 Inpatient Weaning Setting s Residential drug detox program Weaning as part of Comprehensive Pain Management Program* Rapid detox (addressed later) Patient Characteristics On high doses of opioids and/or complex drug regimens or needs more rapid detox Not motivated or resistant to weaning Medium to high psychosocial issues; history of psychiatric diagnosis, prior failed detox Poor community social support for plan Weaning Process Speed of weaning: dose decrease by 20-25% every 3 days Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status Support: Meds for withdrawal (temporary), physical rehabilitation (functional approach), follow-up every day, available by phone daily, proactive check-in, onsite problem resolution; aggressive physical rehabilitation to separate physical from drug issues; multiple modalities to treat withdrawal Case Management Red flags: Increased pain complaints, limited participation, desire to quit program, family support not adequate or detrimental, core beliefs unchanged, anger at carrier, multiple addiction issues. Post-discharge issues. Actions: Family engagement, clear-cut discharge pre-planning regarding pharmacy limitation, approved physicians, day-to-day problem resolution using providers from pain program. Urine drug screens. Onsite psychological support, cognitive behavioral approach.

25 Replacement Therapies Setting s Outpatient: bridge to detoxification Methadone, Buprenorphine products Patient Characteristics On high doses of opioids predominantly Indicated for addiction; very limited as a pain solution Motivated wean off current meds, agrees to terms of process or case who will not wean, out of control Low to medium psychosocial issues Good community social support for plan Weaning Process Speed of weaning: induction requires care, but is relatively quick; subsequent taper is slow Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status Support: Functional restoration, cognitive behavioral therapies, support groups (AA, NA) Case Management Red flags: Lower risk of abuse if no other meds prescribed; pain complaints likely to continue. Patient may advocate to go back on pain medications. Control. Actions: Consider inpatient or outpatient detoxification.

26 Rapid Detoxification Not proven safe or effective Indications: Few, if any. Low doses of narcotics. Claims: Painless, cheaper, safe. Realities: Very risky (high death rate) from coma detoxification, does not treat root of the problem, severe withdrawals and craving on discharge without any support. Risks: Death, suicide due to severe withdrawals, pain not addressed, immediately resuming use of narcotics. Ideal candidate: Maybe patient with no addiction history who medically needs to be off meds ASAP. The data supporting the safety and effectiveness of opioid antagonist agent detoxification under sedation or general anesthesia is limited, and adequate safety has not been established. Given that the adverse events are potentially life threatening, the value of antagonist-induced withdrawal under heavy sedation or anesthesia is not supported.

27 Possible Symptoms of Withdrawal Flu-like aches and pains Sweating, tearing, runny nose Chills, flushing Goose bumps Ants crawling on your skin Loss of appetite Headache Anxiety Restlessness / Restless legs Severe insomnia Nausea, vomiting, diarrhea, abdominal pain

28 PHYSICAL THERAPY

29 S T R E ACTIVE T C H I N PASSIVE G

30 ICE HEAT

31 NEUROMUSCULAR MASSAGE

32 PAIN RELIEF AIDS SELF CARE

33 P R E V E N T I N J U R Y OCCUPATIONAL THERAPY

34 OCCUPATIONAL THERAPY POSTURE BALANCE

35 ERGONOMICS Human Performance Testing Workplace Design / Analysis Job Simulation

36 WORKPLACE ANALYSIS AND DESIGN

37 BIOFEEDBACK THERAPY Relaxation Re-education Body Mechanics Posture

38 MOTOR DYSFUNCTION EVALUATION ABNORMAL

39 PSYCHOLOGY SERVICES Evaluation Manage behavioral crises. Support during Tx Individual, group, family Self Hypnosis Training Relaxation & Stress Management

40 QUESTIONS??

Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH

Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH Western Occupational & Environmental Medical Association CME Webinar April 17, 2013 Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH PLEASE STAND BY - WEBINAR WILL BEGIN

More information

Opioid Treatment Agreement

Opioid Treatment Agreement Opioid Treatment Agreement 1. I understand that my provider and I will work together to find the most appropriate treatment for my chronic pain. I understand the goals of treatment are not to eliminate

More information

Opioid Agreement for Center for Pain Management S.C.

Opioid Agreement for Center for Pain Management S.C. Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these

More information

CONTROLLED SUBSTANCE CONTRACT

CONTROLLED SUBSTANCE CONTRACT CONTROLLED SUBSTANCE CONTRACT The purpose of this contract is to protect my access to controlled substances and to protect our ability to prescribe for you. The long-term use of substances such as opiates

More information

The Challenges of Narcotic Tapering in Chronic Pain Treatment

The Challenges of Narcotic Tapering in Chronic Pain Treatment The Challenges of Narcotic Tapering in Chronic Pain Treatment Speakers: Medical Director, Rosomoff Comprehensive Pain Center, Miami Jewish Health Systems Stuart Sweetser SVP, Clinical Pain Programs, Paradigm

More information

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Jane Jurcic McMaster Family Practice and Hamilton Family Health Team Hamilton, Ontario Opioid Prescribing in Chronic Pain Legitimate

More information

Policy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement

Policy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement Policy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement I understand that I have apain problem that has failed to respond to other treatments. It is recommended that I begin or continue

More information

03/20/12. Recognize the right of patients to appropriate assessment and management of pain

03/20/12. Recognize the right of patients to appropriate assessment and management of pain Narcotic Bowel Syndrome Alvin Zfass M.D. M.D. Professor of Medicine Toufic Kachaamy M.D. GI Fellow Chronic Pain 110 million Americans suffer from chronic pain according to the NIH Cost of untreated t or

More information

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest Treating Addiction in Chronic Pain Patients A Clinical Journey Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest Pain Addiction Kaiser Permanente Northwest 480,000 members

More information

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate

More information

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive. Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.

More information

OPIOID PAIN MEDICATION Agreement and Informed Consent

OPIOID PAIN MEDICATION Agreement and Informed Consent OPIOID PAIN MEDICATION Agreement and Informed Consent I. Introduction Research and clinical experience show that opioid (narcotic) pain medications are helpful for some patients with chronic pain. The

More information

Prescription Drug Abuse

Prescription Drug Abuse Prescription Drug Abuse Introduction Most people take medicines only for the reasons their health care providers prescribe them. But millions of people around the world have used prescription drugs for

More information

CNCP and Addiction. Disclosures 17/02/2015. CPSNS CPSNL Atlantic Mentorship Network P&A. John Fraser February 18, 2015

CNCP and Addiction. Disclosures 17/02/2015. CPSNS CPSNL Atlantic Mentorship Network P&A. John Fraser February 18, 2015 CNCP and Addiction John Fraser February 18, 2015 Disclosures CPSNS CPSNL Atlantic Mentorship Network P&A "Your eyes are fine. It s just that on some eye charts the type is too small." 1 CNCP with history

More information

Pain, Addiction & Methadone

Pain, Addiction & Methadone Pain, Addiction & Methadone A CHALLENGING INTERFACE METHADONE AND SUBOXONE OPIOID SUBSTITUTION CONFERENCE Objectives 2 Explore the interface between concurrent pain and addiction. Appreciate the challenges

More information

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids

More information

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine. What you should know about treating your pain with opioids Important information on the safe use of opioid pain medicine. If your healthcare provider has determined that opioid therapy is right for you,

More information

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid What you need to know about longterm opioid pain care. What you need to know about long-term opioid and the Safety of Others pain care. TAKING What you OPIOIDS need to know about long-term RESPONSIBLY

More information

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com Addiction Medicine for FP / GP Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com S Disease of Chemical Addiction Short Definition of Addiction (ASAM): Addiction is a primary, chronic disease

More information

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011 Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids

More information

William J. Lorman, PhD, MSN, PMHNP-NP, CARN-AP Vice President & Chief Clinical Officer, Livengrin Foundation, Inc. Clinical Asst. Professor, Graduate

William J. Lorman, PhD, MSN, PMHNP-NP, CARN-AP Vice President & Chief Clinical Officer, Livengrin Foundation, Inc. Clinical Asst. Professor, Graduate William J. Lorman, PhD, MSN, PMHNP-NP, CARN-AP Vice President & Chief Clinical Officer, Livengrin Foundation, Inc. Clinical Asst. Professor, Graduate Nursing Dept., Drexel University wlorman@livengrin.org

More information

Share the important information in this Medication Guide with members of your household.

Share the important information in this Medication Guide with members of your household. MEDICATION GUIDE BUPRENORPHINE (BUE-pre-NOR-feen) Sublingual Tablets, CIII IMPORTANT: Keep buprenorphine sublingual tablets in a secure place away from children. Accidental use by a child is a medical

More information

Opiate Abuse and Mental Illness

Opiate Abuse and Mental Illness visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?

More information

PRESCRIPTION DRUG ABUSE prevention

PRESCRIPTION DRUG ABUSE prevention PRESCRIPTION DRUG ABUSE prevention Understanding Drug Addiction Many people do not understand how someone could abuse drugs even when their life seems to be falling apart. It is often assumed that those

More information

Hulpverleningsmodellen bij opiaatverslaving. Frieda Matthys 6 juni 2013

Hulpverleningsmodellen bij opiaatverslaving. Frieda Matthys 6 juni 2013 Hulpverleningsmodellen bij opiaatverslaving Frieda Matthys 6 juni 2013 Prevalence The average prevalence of problem opioid use among adults (15 64) is estimated at 0.41%, the equivalent of 1.4 million

More information

*** Please present this form and all insurance ID cards to the receptionist at this time. ***

*** Please present this form and all insurance ID cards to the receptionist at this time. *** Patient Information Patient Name: Last First M. Mailing Address (incl. city & zip): Permanent Address (incl. city & zip): Phone: Work: Ext: Home: Cell: Date of Birth: Age: SSN: Marital Status: Single /

More information

Protecting your employees, physicians and you.

Protecting your employees, physicians and you. Protecting your employees, physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution - now with real outcomes. Opioids are the most common drugs prescribed in workers

More information

Methamphetamine. Like heroin, meth is a drug that is illegal in some areas of the world. Meth is a highly addictive drug.

Methamphetamine. Like heroin, meth is a drug that is illegal in some areas of the world. Meth is a highly addictive drug. Methamphetamine Introduction Methamphetamine is a very addictive stimulant drug. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she

More information

Treatment of opioid use disorders

Treatment of opioid use disorders Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence

More information

Benzodiazepine Detoxification and Reduction of Long term Use

Benzodiazepine Detoxification and Reduction of Long term Use Benzodiazepine Detoxification and Reduction of Long term Use Malcolm Lader 1 Model of general drug misuse and dependence. Tactical interventional options Social dimension Increasing breaking of social

More information

MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model

MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT An Outpatient Model OBJECTIVE TO PRESENT A PROTOCOL FOR THE EVALUATION AND TREATMENT OF PATIENTS WHO ARE CHEMICALLY DEPENDENT ON OR SEVERLY

More information

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification

More information

The Chemical Coper Steven D. Passik, PhD

The Chemical Coper Steven D. Passik, PhD The Chemical Coper Steven D. Passik, PhD Associate Attending Psychologist Memorial Sloan Kettering Cancer Center New York, NY The Opioid Pendulum Avoidance Even dying people at risk of addiction Balance

More information

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE

More information

Treatments for drug misuse

Treatments for drug misuse Understanding NICE guidance Information for people who use NHS services Treatments for drug misuse NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and

More information

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment

More information

Patients are still addicted Buprenorphine is simply a substitute for heroin or

Patients are still addicted Buprenorphine is simply a substitute for heroin or BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute

More information

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,

More information

Fact Sheet. Queensland Spinal Cord Injuries Service. Pain Management Following Spinal Cord Injury for Health Professionals

Fact Sheet. Queensland Spinal Cord Injuries Service. Pain Management Following Spinal Cord Injury for Health Professionals Pain Management Following Injury for Health Professionals and Introduction Pain is a common problem following SCI. In the case where a person with SCI does have pain, there are treatments available that

More information

PRIMARY CARE PHYSICIAN: REFERRED TO: LAST NAME: FIRST NAME: SS# DOB: SEX: MARITAL STATUS: HOME PHONE: CELL: ADDRESS:

PRIMARY CARE PHYSICIAN: REFERRED TO: LAST NAME: FIRST NAME: SS# DOB: SEX: MARITAL STATUS: HOME PHONE: CELL: ADDRESS: COMPREHENSIVE PAIN CARE OF SOUTH FLORIDA Is this related to an auto accident? Yes No Is this related to a work comp injury? Yes No If yes, is there an attorney involved? Yes No If yes, please list name

More information

THE COMMONWEALTH OF MASSACHUSETTS Department of Industrial Accidents

THE COMMONWEALTH OF MASSACHUSETTS Department of Industrial Accidents THE COMMONWEALTH OF MASSACHUSETTS Department of Industrial Accidents 1 Congress Street, Suite 100 Boston, Massachusetts 02114-2017 DEVAL L. PATRICK Governor PHILIP L. HILLMAN Director TIMOTHY P. MURRAY

More information

MAT Counselor Education Course Exam Questions Packet Part 1

MAT Counselor Education Course Exam Questions Packet Part 1 MAT Counselor Education Course Exam Questions Packet Part 1 Course No: Course Title: Course Objective: MA-1901P1 Medication-Assisted Treatment (MAT) Counselor Education Course Part 1 Includes primer on

More information

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines

More information

How To Know If You Should Be Treated

How To Know If You Should Be Treated Comprehensive ehavioral Care, Inc. delivery system that does not include sufficient alternatives to a particular LOC and a particular patient. Therefore, CompCare considers at least the following factors

More information

OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use

OVERVIEW WHAT IS POLyDRUG USE?  Different examples of polydrug use Petrol, paint and other Polydrug inhalants use 237 11 Polydrug use Overview What is polydrug use? Reasons for polydrug use What are the harms of polydrug use? How to assess a person who uses several drugs

More information

ALCOHOLISM, ALCOHOL DEPENDENCE AND THE EFFECTS ON YOUR HEALTH.

ALCOHOLISM, ALCOHOL DEPENDENCE AND THE EFFECTS ON YOUR HEALTH. ALCOHOLISM, ALCOHOL DEPENDENCE AND THE EFFECTS ON YOUR HEALTH. Alcoholism also known as alcohol dependence is a disabling ADDICTIVE DISORDER. It is characterized by compulsive and uncontrolled consumption

More information

Transitioning a Pain Program Away From Chronic Opioid Prescribing

Transitioning a Pain Program Away From Chronic Opioid Prescribing Transitioning a Pain Program Away From Chronic Opioid Prescribing 1 Steve (Stephen Z. Hull, M.D.) HullS@MercyME.com 2 Transitioning a Pain Program Away From Chronic Opioid Prescribing 3 30% of patients

More information

Substance Abuse Issues in Pain Management

Substance Abuse Issues in Pain Management Substance Abuse Issues in Pain Management Steven D. Passik, PhD Associate Attending Psychologist Memorial Sloan Kettering Cancer Center New York, NY Opioid Rhetoric: From Complete Avoidance to Complete

More information

Prescription Medication Abuse: Skills for Prevention and Intervention

Prescription Medication Abuse: Skills for Prevention and Intervention Prescription Medication Abuse: Skills for Prevention and Intervention icare Partnership www.icarenc.org James Finch, MD North Carolina Society of Addiction Medicine NC Governor s Institute on Alcohol and

More information

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for

More information

Background & Significance

Background & Significance The Impact Of A Structured Opioid Renewal Clinic On Aberrant Drug Behavior Outcomes At A Northeastern VA Medical Center Salimah H. Meghani, PhD, MBE, CRNP Assistant Professor, University of Pennsylvania

More information

It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose.

It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose. MEDICATION GUIDE VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) Read this Medication Guide before you start receiving VIVITROL injections and each time you receive an injection.

More information

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality

More information

Alcohol Addiction. Introduction. Overview and Facts. Symptoms

Alcohol Addiction. Introduction. Overview and Facts. Symptoms Alcohol Addiction Alcohol Addiction Introduction Alcohol is a drug. It is classed as a depressant, meaning that it slows down vital functions -resulting in slurred speech, unsteady movement, disturbed

More information

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015 The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least

More information

Opioid Analgesic Medication Information

Opioid Analgesic Medication Information Opioid Analgesic Medication Information This handout provides information about treating pain with opioid analgesics or narcotics. Please read this entire handout. We want to be sure that you understand

More information

Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal

Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Roger Cicala, M. D. Assistant Medical Director Tennessee Physician s Wellness Program Step 1 Don t 1 It is legal in

More information

How To Treat A Drug Addiction

How To Treat A Drug Addiction 1 About drugs Drugs are substances that change a person s physical or mental state. The vast majority of drugs are used to treat medical conditions, both physical and mental. Some, however, are used outside

More information

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008 PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease

More information

Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model

Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu Disclosure Reckitt Benckiser

More information

Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care

Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care Hull & East Riding Prescribing Committee Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care 1. BACKGROUND Patients who are physically dependent

More information

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is

More information

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents Teen Misuse and Abuse of Alcohol and Prescription Drugs Information for Parents Terminology Misuse: Using a drug in a way in which it was not intended Example: Using a higher dose of medication than was

More information

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH. Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF

More information

TREATMENT MODALITIES. May, 2013

TREATMENT MODALITIES. May, 2013 TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.

More information

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance Introduction Indication/Licensing information: Naltrexone is licensed for use as an additional therapy, within

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,

More information

Interventional Spine Care New Patient History and Intake Form

Interventional Spine Care New Patient History and Intake Form Interventional Spine Care New Patient Introduction You have been referred to Dr. Hamburger/Dr. Olson. Our focus is the evaluation and management of low back pain, and other disorders of the spine. Our

More information

Care Management Council submission date: August 2013. Contact Information

Care Management Council submission date: August 2013. Contact Information Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing

More information

Update and Review of Medication Assisted Treatments

Update and Review of Medication Assisted Treatments Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment

More information

BUPRENORPHINE. the facts about. for Treatment of Opioid Addiction

BUPRENORPHINE. the facts about. for Treatment of Opioid Addiction the facts about BUPRENORPHINE for Treatment of Opioid Addiction U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment

More information

Produced and Published by The Cabin Chiang Mai, Alcohol and Drug Rehab Centre. Copyright 2013. and How is it Treated?

Produced and Published by The Cabin Chiang Mai, Alcohol and Drug Rehab Centre. Copyright 2013. and How is it Treated? and How is it Treated? 1 About this book This E-book has been produced as a guide to help explain some of the fundamental things you need to understand about addiction and its treatment, starting with

More information

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School OPIOIDS Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School Rutgers New Jersey Medical School Fundamentals of Addiction Medicine Summer Series Newark, NJ July 24, 2013

More information

New Patient Evaluation

New Patient Evaluation What area hurts you the most? (Please choose one) When did this pain start? Neck Other: Back How did this pain start? How often do you experience this pain? Describe what this pain feels like. What makes

More information

MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental

More information

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level. Substance-Related Disorders DSM-V Many people use words like alcoholism, drug dependence and addiction as general descriptive terms without a clear understanding of their meaning. What does it really mean

More information

the facts about NALTREXONE

the facts about NALTREXONE the facts about NALTREXONE for Treatment of Opioid Addiction It s not like I woke up one day when I was young and told myself, I wanna be a drug addict. I wanna ruin my life and ruin the lives of those

More information

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES Pursuant to section 453-1.5, Hawaii Revised Statutes, the Board of Medical Examiners ("Board") has established guidelines for physicians with respect to the care and treatment of patients with severe acute

More information

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.

More information

How To Prevent Alcohol And Drug Abuse At Stanford

How To Prevent Alcohol And Drug Abuse At Stanford STANFORD UNIVERSITY Office for Campus Relations Stanford Help Center Alcohol and Drug Abuse Prevention at Stanford Information for Faculty and Staff Phone: 650-723-4577 or Email: helpcenter@lists.stanford.edu

More information

How To Know If You Can Get Help For An Addiction

How To Know If You Can Get Help For An Addiction 2014 FLORIDA SUBSTANCE ABUSE LEVEL OF CARE CLINICAL CRITERIA SUBSTANCE ABUSE LEVEL OF CARE CLINICAL CRITERIA Overview Psychcare strives to provide quality care in the least restrictive environment. An

More information

Experiences of Assessing Misuse, Abuse and Opioid Use Disorders in Patients with Pain on Opioid Therapy

Experiences of Assessing Misuse, Abuse and Opioid Use Disorders in Patients with Pain on Opioid Therapy Experiences of Assessing Misuse, Abuse and Opioid Use Disorders in Patients with Pain on Opioid Therapy Martin D. Cheatle, PhD Center for Studies of Addiction Perelman School of Medicine University of

More information

CONTROLLED SUBSTANCE (NARCOTIC) AGREEMENT

CONTROLLED SUBSTANCE (NARCOTIC) AGREEMENT George A. Frey, MD Zaki G. Ibrahim, MD Nicholas K. Olsen, DO Thomas C. Sanders, PA-C Kai F. Stobbe, PA-C Paul Smith, Administrator Swedish Plaza III 799 E. Hampden Avenue, Suite 500 Englewood, CO 80110-2776

More information

If the only tool you have is a hammer, you tend to see every problem as a nail.

If the only tool you have is a hammer, you tend to see every problem as a nail. How do we approach addiction? ADDICTION 101 A basic primer on addiction If the only tool you have is a hammer, you tend to see every problem as a nail. (Abraham Maslow) Definition of addiction Alcoholism

More information

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15 ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB

More information

Opioids and the Injured Worker Tools for Successful Outcomes

Opioids and the Injured Worker Tools for Successful Outcomes Opioids and the Injured Worker Tools for Successful Outcomes Tim Pokorney, RPh Director, Clinical Express Scripts Workers' Compensation Division Goals and Objectives Alarming statistics for narcotic utilization,

More information

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists, BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module II Opioids 101 Goals for Module II This module reviews the following: Opioid addiction and the brain Descriptions

More information

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635

More information

EPIDEMIOLOGY OF OPIATE USE

EPIDEMIOLOGY OF OPIATE USE Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months

More information

Update on Buprenorphine: Induction and Ongoing Care

Update on Buprenorphine: Induction and Ongoing Care Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference

More information

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University OTC Abuse Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University Opiates Abuse Opioids are a group of natural, partially synthetic, or synthetic drugs

More information

Reintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience

Reintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience Reintegration Recovery Medication-Assisted Treatment for Alcohol Dependence Reintegration Resilience 02 How do you free yourself from the stress and risks of alcohol dependence? Most people cannot do it

More information

methadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment DEPRESSANT Methadone maintenance Pregnancy METHADONE

methadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment DEPRESSANT Methadone maintenance Pregnancy METHADONE methadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment 10 DEPRESSANT Methadone maintenance Pregnancy METHADONE methadonefact.qxd 8/11/01 2:05 PM Page 2 WHAT IS METHADONE

More information

Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3)

Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3) Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3) James Elander University of Derby j.elander@derby.ac.uk http://psychology.derby.ac.uk/staff/james_elander.html SCOOTER

More information

Medication treatments for opioid use disorders

Medication treatments for opioid use disorders Medication treatments for opioid use disorders Summary for counties JUDITH MARTIN, Medical Director of Substance Use Services, San Francisco Department of Public Health Brief history of Methadone and Buprenorphine

More information

Science and Treatment Prescription Drug Addiction Treatment. Karen Miotto, M.D. David Geffen School of Medicine kmiotto@mednet.ucla.

Science and Treatment Prescription Drug Addiction Treatment. Karen Miotto, M.D. David Geffen School of Medicine kmiotto@mednet.ucla. Science and Treatment Prescription Drug Addiction Treatment Karen Miotto, M.D. David Geffen School of Medicine kmiotto@mednet.ucla.edu Presentation Objectives Examine drugs: effects, toxicities, withdrawal

More information

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges

More information

Naltrexone and Alcoholism Treatment Test

Naltrexone and Alcoholism Treatment Test Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score

More information

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,

More information